BA
PFE icon

Boston Advisors’s Pfizer PFE Stock Holding History

Boston Advisors’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$3.43M Sell
100,554
-9,132
-8% -$332K 0.18% 149
2019
Q2 		$4.51M Sell
109,686
-6,973
-6% -$277K 0.24% 113
2019
Q1 		$4.7M Sell
116,659
-12,686
-10% -$508K 0.24% 115
2018
Q4 		$5.36M Buy
129,345
+692
+0.5% +$28.7K 0.31% 88
2018
Q3 		$5.38M Sell
128,653
-3,506
-3% -$135K 0.23% 137
2018
Q2 		$4.55M Sell
132,159
-6,563
-5% -$224K 0.11% 194
2018
Q1 		$4.67M Sell
138,722
-337,056
-71% -$11.6M 0.12% 185
2017
Q4 		$16.4M Sell
475,778
-126
-0% -$4.3K 0.35% 82
2017
Q3 		$16.1M Buy
475,904
+7,493
+2% +$241K 0.37% 84
2017
Q2 		$14.9M Buy
468,411
+139,036
+42% +$4.38M 0.34% 92
2017
Q1 		$10.7M Sell
329,375
-20,325
-6% -$641K 0.25% 130
2016
Q4 		$10.8M Sell
349,700
-285,898
-45% -$8.73M 0.26% 120
2016
Q3 		$20.4M Sell
635,598
-15,771
-2% -$527K 0.5% 50
2016
Q2 		$21.8M Sell
651,369
-1,930
-0.3% -$61.6K 0.54% 44
2016
Q1 		$18.4M Buy
653,299
+2,747
+0.4% +$78.5K 0.45% 61
2015
Q4 		$19.9M Buy
650,552
+493,883
+315% +$15.5M 0.47% 59
2015
Q3 		$4.67M Buy
156,669
+37,919
+32% +$1.22M 0.18% 169
2015
Q2 		$3.78M Sell
118,750
-2,592
-2% -$84.5K 0.16% 159
2015
Q1 		$4M Sell
121,342
-111,663
-48% -$3.55M 0.16% 163
2014
Q4 		$6.89M Sell
233,005
-6,386
-3% -$183K 0.29% 101
2014
Q3 		$6.72M Sell
239,391
-777
-0.3% -$21.8K 0.29% 111
2014
Q2 		$6.76M Buy
240,168
+1,479
+0.6% +$42.2K 0.29% 101
2014
Q1 		$7.27M Sell
238,689
-115,680
-33% -$3.45M 0.32% 93
2013
Q4 		$10.3M Sell
354,369
-16,533
-4% -$481K 0.49% 68
2013
Q3 		$10.1M Sell
370,902
-576,142
-61% -$15.7M 0.54% 63
2013
Q2 		$25.2M Buy
+947,044
New +$26.2M 1.21% 17

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Boston Advisors's PFE Position: Q3 2019 in Review

Boston Advisors reduced its Pfizer (PFE) stake by 8.3% in Q3 2019, selling an estimated $332K and leaving 100,554 shares worth $3.43M. The position accounts for 0.18% of the portfolio, ranked #149.

Boston Advisors first reported a position in PFE in Q2 2013 and has held it in 26 quarters since. The position peaked at $25.2M in Q2 2013. 2,322 funds tracked by Wall St. Rank hold PFE as of Q3 2019.

  • Boston Advisors held 100,554 shares of Pfizer worth $3.43M as of Q3 2019.
  • Boston Advisors sold 9,132 Pfizer shares in Q3 2019, an estimated $332K.
  • Pfizer made up 0.18% of Boston Advisors's portfolio in Q3 2019, its #149 holding.
  • Boston Advisors first reported a position in Pfizer in Q2 2013 and has held it in 26 quarters since.
  • Boston Advisors's Pfizer position peaked at $25.2M in Q2 2013.
  • 2,322 funds tracked by Wall St. Rank held Pfizer as of Q3 2019.

Based on Boston Advisors's 13F filing for Q3 2019, filed 5 Nov 2019.